Advertisement
Screener

X4 PHARMACEUTICALS, INC (XFOR) ROA

X4 PHARMACEUTICALS, INC (XFOR) ROA

  • 2026-06-30: ROA -35.62%.
  • 2026-03-31: ROA -36.90%.
  • 2025-12-31: ROA -27.27%.
  • 2025-09-30: ROA -58.14%.

Complete source-backed roa history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-35.62%
2026-03-31-36.90%
2025-12-31-27.27%
2025-09-30-58.14%
2025-06-30-96.96%
2025-03-3111.23%
2024-12-31-25.57%
2024-09-30-9.41%
2024-06-308.37%
2024-03-31-114.91%
2023-12-31-68.70%
2023-09-30-64.13%
2023-06-30-75.21%
2023-03-31-77.10%
2022-12-31-60.33%
2022-09-30-83.74%
2022-06-30-115.48%
2022-03-31-92.33%
2021-12-31-75.69%
2021-09-30-63.80%
2021-06-30-52.35%
2021-03-31-43.26%
2020-12-31-50.57%
2020-09-30-40.99%
2020-06-30-38.47%
2020-03-31-34.53%
2019-12-31-32.86%
2019-09-30-48.62%
2019-06-30-33.06%
2019-03-31-58.82%
2018-12-31-334.72%
2018-09-30-46.42%
2018-06-30-42.48%
2018-03-31-34.64%
2017-12-31-27.07%

Annual ROA

DateROA
2025-12-31-27.27%
2024-12-31-25.57%
2023-12-31-68.70%
2022-12-31-60.33%
2021-12-31-75.69%
2020-12-31-50.57%
2019-12-31-32.86%
2018-12-31-334.72%
2017-12-31-27.07%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Ocugen, Inc. (OCGN)United States$0.343B-6.34